References
- Grajek M, Krupa-Kotara K, Białek-Dratwa A, et al. Nutrition and mental health: A review of current knowledge about the impact of diet on mental health. Front Nutr, 2022, 9: 943998.
- World Health Organization. WHO Facts Sheets. [Internet]. Available at: https://www.who.int/news-room/fact-sheets (Accessed: 30 January 2025).
- Rajan TM, Menon V. Psychiatric disorders and obesity: A review of association studies. J Postgrad Med, 2017, 63(3): 182–190.
- Adan RAH, van der Beek EM, Buitelaar JK, et al. Nutritional psychiatry: towards improving mental health by what you eat. Eur Neuropsychopharmacol, 2019, 29(12): 1321–1332.
- Al-Snafi AE. A review on pharmacological activities of Kochia scoparia – a review. Indo Am J P Sci, 2018, 05(04): 2213–2221.
- Fulton S, Décarie-Spain L, Fioramonti X, et al. The menace of obesity to depression and anxiety prevalence. Trends Endocrinol Metab, 2022, 33(1): 18–35.
- Więckowska-Gacek A, Mietelska-Porowska A, Wydrych M, et al. Western diet as a trigger of Alzheimer’s disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration. Ageing Res Rev, 2021, 70: 101397.
- Lu Z, Pu C, Zhang Y, et al. Oxidative stress and psychiatric disorders: evidence from the bidirectional mendelian randomization study. Antioxidants, 2022, 11(7): 1386.
- Calder PC, Ahluwalia N, Brouns F, et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr, 2011, 106 (Suppl 3): S5–S78.
- Dyer AH, McNulty H, Caffrey A, et al. Low-Grade systemic inflammation is associated with domain-specific cognitive performance and cognitive decline in older adults: Data from the TUDA study. Neurobiol Aging, 2024, 134: 94-105.
- Osimo EF, Cardinal RN, Jones PB, et al. Prevalence and correlates of low-grade systemic inflammation in adult psychiatric inpatients: An electronic health record-based study. Psychoneuroendocrinology, 2018, 91: 226–234.
- Katuri RB, Gaur GS, Sahoo JP, et al. Association of circulating brain-derived neurotrophic factor with cognition among adult obese population. J Obes Metab Syndr, 2021, 30(2): 163–172.
- Cho HD, Kim JH, Park JK, et al. Kochia scoparia seed extract suppresses VEGF-induced angiogenesis via modulating VEGF receptor 2 and PI3K/AKT/mTOR pathways. Pharm Biol, 2019, 57(1): 684–693.
- Gudoityte E, Arandarcikaite O, Mazeikiene I, et al. Ursolic and oleanolic acids: plant metabolites with neuroprotective potential. Int J Mol Sci, 2021, 22(9): 4599.
- Dinan L, Dioh W, Veillet S, et al. 20-Hydroxyecdysone, from plant extracts to clinical use: therapeutic potential for the treatment of neuromuscular, cardio-metabolic and respiratory diseases. Biomedicines, 2021, 9(5): 492.
- Fan L, Peng Y, Li X. Brain regional pharmacokinetics of hydroxytyrosol and its molecular mechanism against depression assessed by multi-omics approaches. Phytomedicine, 2023, 112: 154712.
- Sharma D, Singh M, Kumar P, Vikram V, et al. Development and characterization of morin hydrate loaded microemulsion for the management of Alzheimer’s disease. Artific Cells Nanomed Biotechnol, 2017, 45(8): 1620–1630.
- Verma N, Raghuvanshi DS, Singh RV. Recent advances in the chemistry and biology of oleanolic acid and its derivatives. Eur J Med Chem, 2024, 276: 116619.
- Jeon SJ, Lee HJ, Lee HE, et al. Oleanolic acid ameliorates cognitive dysfunction caused by cholinergic blockade via TrkB-dependent BDNF signaling. Neuropharmacology, 2017, 113(Pt A): 100–109.
- Zwetsloot, K, van Onselen L, Moorefield E, et al. Effect of 20-hydroxyecdysone on the immune response following eccentric muscle injury in C57BL/6 mice. Physiology, 2023, 38: S1.
- Bertelli M, Kiani AK, Paolacci S, et al. Hydroxytyrosol: a natural compound with promising pharmacological activities. J Biotechnol, 2020, 309: 29–33.
- Calahorra J, Shenk J, Wielenga VH, et al. Hydroxytyrosol, the major phenolic compound of olive oil, as an acute therapeutic strategy after ischemic stroke. Nutrients, 2019, 11(10): 2430.
- Rajput, SA, Wang XQ, Yan HC. Morin hydrate: A comprehensive review on novel natural dietary bioactive compound with versatile biological and pharmacological potential. Biomed Pharmacother, 2021, 138: 111511.
- Abtulov M, Zhelyazkova-Savova M, Gancheva S, et al. Effect of Kochia scoparia on carrageenan-induced paw edema in an experimental model of metabolic syndrome. Bulg Chem Comm, 2020, 52(D): 75-77.
- Gancheva S, Tzaneva M, Valcheva-Kuzmanova S, et al. Antiobesity, antioxidant and hepatoprotective properties of aqueous infusion of Kochia scoparia seeds in rats with diet-induced metabolic syndrome. Bulg Chem Comm, 2020, 52(D): 60-67.